THERMOGENESIS (KOOL)
THERMOGENESIS Debt to Equity Ratio: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
KOOL Debt to Equity Ratio Rankings
| Overall | 99th percentile | 1 of 4263 |
| Sector | 99th percentile | 1 of 476 in Healthcare |
| Industry | 98th percentile | 1 of 71 in Medical Appliances & Equipment |
KOOL Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 0.0006 | Jun 2007 |
| Average | 0.0001 |
About Debt to Equity Ratio
YCharts Calculation: Debt to Equity = (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity
The debt to equity ratio is a leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. It reveals how a company has financed its assets. A low debt to equity ratio indicates lower risk because shareholder's have claims on a larger portion of the company's assets.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
You may also be interested in these KOOL related companies
KOOL News
ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
May 07, 12:30PM PR Newswire
May 07, 12:30PM PR Newswire
ThermoGenesis Announces AABB Accreditation for Cord Blood Products Customer in China
Mar 29, 2:00PM PR Newswire
Mar 29, 2:00PM PR Newswire
ThermoGenesis Announces Webcast of Presentation at Roth Capital Conference
Mar 07, 12:30PM PR Newswire
Mar 07, 12:30PM PR Newswire
ThermoGenesis Corp. to Announce Second Quarter Fiscal 2012 Results on February 9, 2012
Feb 06, 2:56PM PR Newswire
Feb 06, 2:56PM PR Newswire
ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference
Feb 01, 9:00AM PR Newswire
Feb 01, 9:00AM PR Newswire
ThermoGenesis Announces Management Transition; CFO Matthew Plavan to Become CEO
Jan 30, 4:27PM Benzinga
Jan 30, 4:27PM Benzinga
ThermoGenesis Announces Management Transition in Conjunction With Tactical Realignment of Company
Jan 30, 4:25PM PR Newswire
Jan 30, 4:25PM PR Newswire
ThermoGenesis Announces Webcast of Presentation at OneMedForum Conference
Jan 05, 9:00AM PR Newswire
Jan 05, 9:00AM PR Newswire
India's Ministry of Health Approves ThermoGenesis' (KOOL) AutoXpress System
Jan 04, 1:44PM Street Insider
Jan 04, 1:44PM Street Insider
$KOOL filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/nO8
about 217 days ago by MarketBrief
about 217 days ago by MarketBrief
About low priced stocks (penny stocks), $KOOL, etc., one I like (in part bec few others do) is $FCSC; regen cosmetic med; altern to BOTOX?
about 247 days ago by BioDude
about 247 days ago by BioDude
$KOOL tech used to harvest & store stem cells; the BIG event might be the dev of signif stem cell therapies; not sure there's one yet?
about 247 days ago by BioDude
about 247 days ago by BioDude
$KOOL bought 1150 shares on the low volume day at 2.02508 hoping for move up
about 328 days ago by powers123
about 328 days ago by powers123
5 Stocks Ready for a Bounce: $MCD $LOW $SHLD $KOOL $MDT http://stk.ly/jkBEdz
about 358 days ago by SharePlanner
about 358 days ago by SharePlanner
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| KOOL | 0.81 | +0.00 | +0.00% | 13.29M |
| KONA | 7.85 | -0.04 | -0.51% | 69.43M |
| KOL | 25.44 | -0.73 | -2.79% | |
| KOG | 8.395 | -0.35 | -4.06% | 2.302B |
| KOF | 113.20 | -1.25 | -1.09% | 21.13B |
| KO | 75.08 | -0.38 | -0.50% | 170.88B |
| KNXA | 29.79 | -0.72 | -2.36% | 831.40M |
| IL | 4.10 | -0.11 | -2.61% | 230.50M |
| IKNX | 8.00 | +0.09 | +1.14% | 15.92M |
| IKAN | 0.87 | +0.01 | +0.58% | 59.98M |
